BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8556068)

  • 1. Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
    Kamel N; Uysal AR; Cesur V; Erdoğan G; Başkal N
    Endocr J; 1995 Aug; 42(4):581-6. PubMed ID: 8556068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
    Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
    Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
    Bronstein MD
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):130-1. PubMed ID: 16932269
    [No Abstract]   [Full Text] [Related]  

  • 7. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
    Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of large prolactinoma supposed to be cured by bromocriptine therapy.
    Arita K; Uozumi T; Ohta M
    Endocrinol Jpn; 1988 Jun; 35(3):503-9. PubMed ID: 3197661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late development of resistance to bromocriptine in a patient with macroprolactinoma.
    Delgrange E; Crabbé J; Donckier J
    Horm Res; 1998; 49(5):250-3. PubMed ID: 9568811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achievement of fertility in an infertile man with resistant macroprolactinoma using high-dose bromocriptine and a combination of human chorionic gonadotropin and an aromatase inhibitor.
    Heidari Z; Hosseinpanah F; Shirazian N
    Endocr Pract; 2010; 16(4):669-72. PubMed ID: 20439242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse.
    Rohmer V; Freneau E; Morange I; Simonetta C
    Ann Endocrinol (Paris); 2000 Nov; 61(5):411-7. PubMed ID: 11084391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
    Hartman N; Voron SC; Hershman JM
    Headache; 1995; 35(7):430-1. PubMed ID: 7672963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
    Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroprolactinomas as cause of delayed puberty. A report of two cases and effects of medical therapy.
    Minniti G; Jaffrain-Rea ML; Ferretti E; Gulino A; Tamburrano G
    Minerva Endocrinol; 1996 Jun; 21(2):67-71. PubMed ID: 8968149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
    Sabuncu T; Arikan E; Tasan E; Hatemi H
    Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cabergoline and recombinant human growth hormone treatment of an adolescent with a macroprolactinoma causing GH deficiency.
    Cesario F; Borretta G; Meineri I; Muratori M; Pizzocaro A; Beck-Peccoz P
    J Pediatr Endocrinol Metab; 1997; 10(2):231-6. PubMed ID: 9364359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review.
    Oh YJ; Lee WS; Yoo WH; Hahm JR; Kim HO; Suh YS; Lee SI; Cheon YH
    Int J Rheum Dis; 2017 Nov; 20(11):1823-1826. PubMed ID: 26355497
    [No Abstract]   [Full Text] [Related]  

  • 20. Large macroprolactinoma treated with bromocriptine alone.
    Loh KC; Shlossberg AH
    Ann Acad Med Singap; 1996 Nov; 25(6):886-9. PubMed ID: 9055023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.